Artigo · Revista · 2013

Endogenous factor VIII synthesis from the intron 22–inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

the PATH (Personalized Alternative Therapies for Hemophilia) Study Investigators, Gouri Shankar Pandey, Chen Yanover, Lisa M Miller-Jenkins, Susan Garfield, Shelley A. Cole e mais 11

Nature Medicine

• Acesso aberto · Verde
• 10% mais citados do mundo
• Com uma empresa
• Internacional · 4 países

Lê-lo10.1038/nm.3270